GALVmed Commercial Development strategic goals are to improve market supply and adoption of key animal health products for small-scale producers (SSP), and encourage significantly increased investment in the SSP sector by the animal health industry.
GALVmed’s commercial development activities are underwritten by the willingness of small-scale livestock producers to pay the market price for effective livestock health products, particularly vaccines, and services. It is this commercial principle that will allow GALVmed to achieve its ultimate vision of vaccines and other essential animal health products being widely available to SSPs around the globe.
One of the goals of GALVmed’s commercial development work is to establish large-scale distribution systems providing access to animal health products and services for SSPs in Sub-Saharan Africa which…
- …are profitable and therefore sustainable post-funding, and which…
- …show the way for the Animal Health industry more generally to engage with the small-scale market…
- …resulting in significant positive economic impact.
This will be achieved by identifying and resolving barriers across the whole supply chain in an interconnected manner, from market entry to distribution and service provision, while also scaling innovation to last mile through market intelligence platform solutions focused on serving SSP needs.
GALVmed’s commercial development function will continue to test and demonstrate the underlying business case for the establishment of distribution networks for the small-scale segment. With the animal health industry fully engaged in this way, hundreds of millions of SSPs around the world can have access to affordable and vitally needed agricultural inputs – livestock vaccines and medicines.
